Human immunodeficiency virus (HIV) attacks the human body’s immune system. HIV infection has become a major global public health issue due to its increasing number of cases yearly. Since the first HIV case was reported in 1987 in Bali, Indonesia, it is estimated that HIV cases have spread to 386 cities throughout numerous provinces in Indonesia1. The Joint United Nations Program on HIV/acquired immunodeficiency syndrome (AIDS) (UNAIDS) estimates that the number of adults and children newly infected with HIV worldwide at the end of 2022 had decreased by 59% since the peak in 1995. Approximately 1.3 million (1–1.7 million) people were newly infected with HIV, compared to 3.2 million (2.5–4.3 million) people in 1995. However, people living with HIV with access to antiretroviral therapy (ART) were only 76% (65–89%)2. Meanwhile, the new HIV infections in Indonesia by the end of 2022 have been reduced by 52% since 2010. However, AIDS-related deaths have increased by 60% since 2010, and the incidence–mortality ratio also increased with only 33% coverage of ART among Indonesians living with HIV/AIDS. Thus, HIV/AIDS has evidently become a serious health problem in this country3, and Indonesia has the largest number of HIV infection cases in Southeast Asia. There are three mechanisms of HIV transmission: (1) vertical transmission from HIV-infected mother to child (during pregnancy, delivery, and breast-feeding), (2) sexual transmission (homosexual or heterosexual), and (3) horizontal transmission through blood transfusion or contaminated blood transfusion (e.g., sharing injection material, tattoo, piercing, blood transfusion, organ transplantation, hemodialysis, and dental care)4,5.
Generally, recent HIV infection cases in Indonesia have been dominated by horizontal transmission through sexual intercourse, which comprises 89% of the total cases6. HIV cases were generally concentrated among key affected populations due to their high-risk sexual intercourse behavior. The key affected population was commonly female sex workers, male who have sex with male, transgenders, and people who inject drugs. Among these key populations, HIV-infected prevalence reach 30%, which is 100 times higher compared to HIV-infected prevalence in general adult residents (0.3%)7.
HIV has a high mutation rate, leading to a high level of genetic variation. Currently, HIV is classified into two types: HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is classified into groups M (main), O (outline), N (new or nonM/nonO), and P (pending). Among them, group M viruses cause a pandemic. Group M is further divided into nine subtypes (A, B, C, D, F, G, H, J, and K) and several circulating recombinant forms (CRFs) generated by the intersubtypes and genomic recombination of CRFs. The global distribution of HIV-1 subtypes and CRFs is possibly affected by several factors, such as migration, cultural changes, social and political factors, international trades, and human genetics8.
Subtype B has been the most prevalent subtype of HIV-1 in the Americas, Europe, and Australia, whereas other subtypes and CRFs are more prevalent in Africa and Asia9. CRF01_AE, one of the most widespread CRFs in the world, has spread throughout Southeast Asia, including Thailand, the Philippines, Singapore, and Vietnam10,11. CRF01_AE is the earliest identified CRF in Thailand and has spread over Southeast Asian countries12. It is the dominant HIV-1 CRF in Southeast Asia and other Asian countries, but information regarding the molecular dynamics of CRF01_AE is still limited. Some research has reported that CRF01_AE is the most dominant HIV-1 CRF in Indonesia13,14. Monitoring the molecular dynamics of CRF01_AE HIV-1 using the phylogenetic approach was especially necessary to acknowledge characteristic evolution, spatial transmission, and temporal transmission of HIV-1 in the region15.
The molecular dynamics of HIV-1 is not only about identifying the molecular dynamic epidemiology, but it also involves identifying its influence in providing suitable therapy and vaccine15. The different immunological responses consider the need for a suitable therapy given according to the infected HIV-1 subtype or CRF16. In addition to therapy, HIV-1 genetics has emerged as the main challenge in developing a vaccine. Mutations that arise due to the HIV-1 evolution might be changing virus characteristics, including pathogenesis and antigenesis. Therefore, developing a vaccine based on the region’s most prevalent HIV-1 subtype or CRF may be more advantageous for eliciting an adequate immune response corresponding to the strain that will most likely cause infection5,15.
As a country with a high incidence of HIV-1 infection in Southeast Asia17, Indonesia may contribute to the spread of HIV to other Asian countries, particularly in the context of CRF01_AE viruses. Concern about its potential contribution has raised significantly. However, information on the evolution of dynamic transmission characteristic, spatial transmission, and temporal HIV-1 CRF01_AE in Indonesia is lacking. The lack of such information poses a significant challenge in effectively combating the HIV epidemic. Therefore, this study uses the phylogenetic approach to analyze the characteristic evolution, spatial transmission, and temporal transmission of HIV-1 CRF01_AE in Indonesia. This analysis was performed on sequences of nearly full-length HIV-1 CRF01_AE genomes obtained from HIV-1-infected individuals in multiple regions of Indonesia. This study can provide valuable information that is not only important for Indonesia but also has broader implications for controlling and preventing HIV-1 transmission in the wider Asian region.